An upstart biopharma firm founded by two former executives at CinCor Pharma – which celebrated a $1.8B exit to AstraZeneca in ...

Piper Sandler analyst maintains an Overweight rating on Teva, citing positive feedback on duvakitug's potential in treating ...

Barclays analyst Balaji Prasad maintained a Buy rating on Teva Pharmaceutical (TEVA – Research Report) today and set a price target of $28.00.

In a report released today, David Amsellem from Piper Sandler reiterated a Buy rating on Teva Pharmaceutical (TEVA – Research Report), with a ...

The company will report earnings before the open on Jan. 29 Israel-based pharmaceutical giant Teva Pharmaceutical Industries Ltd (NYSE:TEVA) is preparing for its latest quarterly earnings report, due ...

Teva Pharmaceutical Industries Ltd. and Samsung Bioepis Co., Ltd. announced that they entered into a licensing ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Anti-Fungal Therapy Market. The global anti-fungal therapy market is set to experience significant growth, with a projected ...

The drugs listed are in alphabetical order. Bendamustine hydrochloride injection: Apotex on Jan. 27 reported the discontinuation of both the 25 mg and 100 mg presentations of bendamustine ...

Bank Leumi (TASE: LUMI) led the market today, rising 0.79% on the day's biggest trading turnover. Mizrahi Tefahot Bank rose 0.60%, Bank Hapoalim (TASE: POLI) rose 0.88%, and Israel Discount Bank (TASE ...

The unregulated nature of the trade in medicines during this period ensured there was a far less strict delineation between 'pharmaceutical' and 'chemical' industries than we have nowadays.

In recent years, the number of major drug recalls within the Pharmaceutical industry has skyrocketed from 426 in 2008 to 1,742 in 2009 according to CNNMoney. 1 Even more alarming is the increase ...